| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3337 | 2020 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1512 | 2020 |
| SARS-CoV-2 evolution during treatment of chronic infection. TN Kemp SA, Collier DA, Datir RP, Ferreira IATM, Gayed S, Jahun A, Hosmillo ... Nature, 2021 | 913 | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 901 | 2022 |
| Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans M Roberts, D Driggs, M Thorpe, J Gilbey, M Yeung, S Ursprung, ... Nature Machine Intelligence 3 (3), 199-217, 2021 | 835 | 2021 |
| STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis FL van de Veerdonk, TS Plantinga, A Hoischen, SP Smeekens, ... New England Journal of Medicine 365 (1), 54-61, 2011 | 721 | 2011 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 716 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 576* | 2021 |
| GeoSentinel surveillance of illness in returned travelers, 2007–2011 K Leder, J Torresi, MD Libman, JP Cramer, F Castelli, P Schlagenhauf, ... Annals of internal medicine 158 (6), 456-468, 2013 | 556 | 2013 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 484* | 2021 |
| Clinical management of Staphylococcus aureus bacteraemia GE Thwaites, JD Edgeworth, E Gkrania-Klotsas, A Kirby, R Tilley, ... The Lancet infectious diseases 11 (3), 208-222, 2011 | 338 | 2011 |
| Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation P Schlagenhauf, L Weld, A Goorhuis, P Gautret, R Weber, ... The Lancet Infectious Diseases 15 (1), 55-64, 2015 | 295 | 2015 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 278 | 2021 |
| Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website H Erdem, DR Lucey International Journal of Infectious Diseases 102, 239-241, 2021 | 261 | 2021 |
| Illness in children after international travel: analysis from the GeoSentinel Surveillance Network S Hagmann, R Neugebauer, E Schwartz, C Perret, F Castelli, ED Barnett, ... Pediatrics 125 (5), e1072-e1080, 2010 | 222 | 2010 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies E Gkrania-Klotsas, Z Ye, AJ Cooper, SJ Sharp, R Luben, ML Biggs, ... PloS one 5 (10), e13405, 2010 | 211 | 2010 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996–2008 M Jensenius, X Davis, F Von Sonnenburg, E Schwartz, JS Keystone, ... Emerging infectious diseases 15 (11), 1791, 2009 | 190 | 2009 |
| Travel and migration associated infectious diseases morbidity in Europe, 2008 V Field, P Gautret, P Schlagenhauf, GD Burchard, E Caumes, ... BMC Infectious Diseases 10, 1-12, 2010 | 186 | 2010 |
Eli SchwartzProfessor of Medicine, Tel Aviv University and Sheba Medical CenterVerified email at post.tau.ac.il
